Biotech

CoreWorks

CoreWorks Raises $75M Series B to Transform Biotech

$75M Series B
Total Raised
Series
Latest Round
2018
Founded
100-250
Employees
Washington, DC
1 min read

Quick Facts

Valuation
$500M
Latest Round Size
$75M Series B
Latest Round Date
October 2025

CoreWorks Raises $75M Series B in Latest Funding Round

CoreWorks has successfully closed a $75M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by 500 Startups, with participation from General Catalyst.

Company Overview

Founded in 2018 and headquartered in Washington, DC, CoreWorks has established itself in the Biotech space. Leading machine learning platform automating enterprise workflows with advanced AI models

With a current valuation of $500M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $75M Series B
  • Valuation: $500M
  • Lead Investor: 500 Startups

Future Outlook

As CoreWorks moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.

Key Investors

500 Startups
Venture Capital
Leading venture capital firm investing in technology companies
General Catalyst
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

David Chen
David Chen
Technology investment researcher specializing in enterprise software and infrastructure deals at top-tier venture funds.